A detailed history of Spire Wealth Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Spire Wealth Management holds 79,996 shares of EW stock, worth $7.39 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
79,996
Previous 81,351 1.67%
Holding current value
$7.39 Million
Previous $6.2 Million 23.23%
% of portfolio
0.25%
Previous 0.21%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$72.54 - $95.56 $98,291 - $129,483
-1,355 Reduced 1.67%
79,996 $7.64 Million
Q4 2023

Feb 06, 2024

BUY
$61.71 - $77.76 $1.44 Million - $1.81 Million
23,278 Added 40.08%
81,351 $6.2 Million
Q3 2023

Nov 08, 2023

SELL
$69.28 - $93.38 $2.38 Million - $3.2 Million
-34,305 Reduced 37.14%
58,073 $4.02 Million
Q2 2023

Aug 09, 2023

BUY
$81.41 - $94.33 $4.07 Million - $4.72 Million
50,009 Added 118.03%
92,378 $8.71 Million
Q1 2023

May 09, 2023

BUY
$74.26 - $84.51 $2.46 Million - $2.8 Million
33,132 Added 358.69%
42,369 $3.51 Million
Q4 2022

Feb 03, 2023

SELL
$68.3 - $87.44 $13,864 - $17,750
-203 Reduced 2.15%
9,237 $689,000
Q3 2022

Nov 07, 2022

SELL
$82.37 - $107.29 $97,608 - $127,138
-1,185 Reduced 11.15%
9,440 $780,000
Q2 2022

Jul 22, 2022

SELL
$86.5 - $128.27 $481,718 - $714,335
-5,569 Reduced 34.39%
10,625 $1.01 Million
Q1 2022

Apr 18, 2022

SELL
$101.96 - $128.34 $358,389 - $451,115
-3,515 Reduced 17.83%
16,194 $1.91 Million
Q4 2021

Jan 14, 2022

BUY
$106.37 - $130.68 $373,145 - $458,425
3,508 Added 21.65%
19,709 $2.55 Million
Q3 2021

Oct 22, 2021

BUY
$102.91 - $122.75 $89,325 - $106,547
868 Added 5.66%
16,201 $1.83 Million
Q2 2021

Jul 26, 2021

SELL
$83.84 - $104.76 $253,951 - $317,318
-3,029 Reduced 16.5%
15,333 $1.65 Million
Q1 2021

May 21, 2021

BUY
$78.68 - $90.67 $1.44 Million - $1.66 Million
18,362 New
18,362 $1.53 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.